Mattes Glenn R. 4
4 · TFF Pharmaceuticals, Inc. · Filed Sep 16, 2021
Insider Transaction Report
Form 4
Mattes Glenn R.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2021-09-16$7.10/sh+10,000$71,000→ 20,000 total
Holdings
- 7,000(indirect: By Spouse)
Common Stock